| Q38090524 | (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis |
| Q33564610 | 18F-FDG PET/CT for the assessment of myocardial sarcoidosis |
| Q89287664 | 18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake |
| Q47679382 | A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the Ame |
| Q57621344 | ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures |
| Q27024252 | Assessment of cardiac sarcoidosis with advanced imaging modalities |
| Q42220130 | Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging |
| Q47258811 | Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis |
| Q44823568 | Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. |
| Q97428269 | Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients |
| Q53056214 | Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease. |
| Q34216096 | Comparison of methods to reduce myocardial 18F-FDG uptake in mice: calcium channel blockers versus high-fat diets |
| Q44184599 | Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis |
| Q35843724 | Detection of Myocardial Metabolic Abnormalities by 18F-FDG PET/CT and Corresponding Pathological Changes in Beagles with Local Heart Irradiation |
| Q57802682 | Effect of blood glucose level on standardized uptake value (SUV) in F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements |
| Q34147045 | Effect of duration of fasting and diet on the myocardial uptake of F-18-2-fluoro-2-deoxyglucose (F-18 FDG) at rest |
| Q38979681 | Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake |
| Q57688671 | Effects of a Ketogenic Diet on [18F]FDG-PET Imaging in a Mouse Model of Lung Cancer |
| Q51287147 | Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging. |
| Q50905653 | FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation. |
| Q41195415 | High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients |
| Q54644191 | Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. |
| Q88668462 | Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring |
| Q89691401 | Myocardial Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis: Specialized Protocols for Better Diagnosis |
| Q37703212 | Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation |
| Q26781838 | Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques |
| Q54741207 | Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation. |
| Q52364999 | PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction. |
| Q38859249 | Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. |
| Q37718443 | Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. |
| Q56764232 | Somatostatin receptor based hybrid imaging in sarcoidosis |
| Q47831315 | Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model. |
| Q88803526 | The logic and challenges of imaging sarcoidosis with whole body FDG PET |
| Q44671159 | Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. |
| Q45403909 | Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis? |